SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-015985
Filing Date
2021-05-05
Accepted
2021-05-05 17:12:03
Documents
7
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10023502x1_def14a.htm DEF 14A 665333
2 logo_aquestive-reg.jpg GRAPHIC 54294
3 logo_aquestive-regx1.jpg GRAPHIC 43389
4 nc10023502x1_pc01.jpg GRAPHIC 739456
5 nc10023502x1_pc02.jpg GRAPHIC 634798
6 sig_keithjkendall.jpg GRAPHIC 18982
7 sig_lorijbraenderx1.jpg GRAPHIC 26060
  Complete submission text file 0001140361-21-015985.txt   2754506
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38599 | Film No.: 21894497
SIC: 2834 Pharmaceutical Preparations